Arphra
live
S&P 5007,500.58+1.08%
NASDAQ30,406.19+2.48%
DOW51,564.7+0.14%
VIX16.78+2.32%
US10Y4.45-0.27%
EUR/USD1.1506-0.93%
GOLD4,300.5-1.26%
WTI75.22-0.90%
BTC64,442.01-1.87%
S&P 5007,500.58+1.08%
NASDAQ30,406.19+2.48%
DOW51,564.7+0.14%
VIX16.78+2.32%
US10Y4.45-0.27%
EUR/USD1.1506-0.93%
GOLD4,300.5-1.26%
WTI75.22-0.90%
BTC64,442.01-1.87%

DGX

Quest Diagnostics Incorporated
HealthcareMedical - Diagnostics & ResearchUSUSDPeers →
$195.00
-0.86%LiveJun 18, 2026
AI Brief
Market cap
$21.59B
52w range
164.65 – 213.50
P / E
—
EPS · FY 2025
$8.75
Volume
677.78K
Revenue · FY 2025
$11.04B
+11.78% YoY
OverviewFundamentalsValuationMarketOwnership & flowNarrative & AI
PricesTrendEarningsEstimatesCall languageAnalystsRelated securities

Explain this page

Arphra AI
Equity listings
2
Corporate bonds
0
Convertibles
0
Peer equities
10
Equity
· 2 venues

Cross-listings

SymbolExchangeCtryCcyMkt cap
DGXprimaryNew York Stock ExchangeusUSD$21.59B
0KSX.LLondon Stock ExchangeusUSD$215.25M
Listed options →
Equity
· 10 names

Peer companies

  • UTHRUnited Therapeutics Corporation$25B
  • WSTWest Pharmaceutical Services, Inc.$21.24B
  • LHLabcorp Holdings Inc.$21.06B
  • ILMNIllumina, Inc.$20.63B
  • INCYIncyte Corporation$19.36B
  • WATWaters Corporation$18.28B
  • THCTenet Healthcare Corporation$16.06B
  • ZBHZimmer Biomet Holdings, Inc.$16.05B
  • MEDPMedpace Holdings, Inc.$11.92B
  • ICLRICON Public Limited Company$8.62B
Fixed income
· no mapped debt

Corporate bonds

No corporate bonds mapped to this issuer’s LEI. Many equity-only names carry no public debt, or the LEI bridge isn’t resolved yet.

AI read · securities complex

Arphra AI